E&C Passes PBM Reforms, But Refinements Likely Before House Vote

By Gabrielle Wanneh / December 6, 2023 at 8:01 PM
The House Energy & Commerce Committee on Wednesday (Dec. 6) advanced a final cluster of pharmacy benefit manager reforms and drug pricing policies this year that aim to lower the costs of Medicare Part D prescription drugs for beneficiaries at the pharmacy counter, but some of the bills likely won’t face a House floor vote until they are further refined. It is also unclear how the E&C’s latest PBM bills, which are similar to those advanced by the Senate Finance...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.